AU656832B2 - Anti-rheumatic naphthyridine derivatives - Google Patents

Anti-rheumatic naphthyridine derivatives Download PDF

Info

Publication number
AU656832B2
AU656832B2 AU31587/93A AU3158793A AU656832B2 AU 656832 B2 AU656832 B2 AU 656832B2 AU 31587/93 A AU31587/93 A AU 31587/93A AU 3158793 A AU3158793 A AU 3158793A AU 656832 B2 AU656832 B2 AU 656832B2
Authority
AU
Australia
Prior art keywords
group
formula
represents hydrogen
alkyl group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31587/93A
Other languages
English (en)
Other versions
AU3158793A (en
Inventor
Bernard John Armitage
John Gareth Bowen
Malcolm John Crossley
Ian Michael Hunneyball
Bruce William Leslie
Thomas Kerr Miller
Michael Spowage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of AU3158793A publication Critical patent/AU3158793A/en
Application granted granted Critical
Publication of AU656832B2 publication Critical patent/AU656832B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU31587/93A 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives Ceased AU656832B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
GB9127252 1991-12-23
PCT/EP1992/002901 WO1993013097A1 (en) 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂

Publications (2)

Publication Number Publication Date
AU3158793A AU3158793A (en) 1993-07-28
AU656832B2 true AU656832B2 (en) 1995-02-16

Family

ID=36822317

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31587/93A Ceased AU656832B2 (en) 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives

Country Status (22)

Country Link
US (1) US5464781A (enExample)
EP (1) EP0618916B1 (enExample)
JP (1) JP2527917B2 (enExample)
CN (1) CN1096784A (enExample)
AT (1) ATE171452T1 (enExample)
AU (1) AU656832B2 (enExample)
BG (1) BG98813A (enExample)
CA (1) CA2125858A1 (enExample)
CZ (1) CZ153594A3 (enExample)
DE (1) DE69227125T2 (enExample)
FI (1) FI943019A0 (enExample)
GB (1) GB9127252D0 (enExample)
HR (1) HRP921455A2 (enExample)
HU (1) HUT66971A (enExample)
IL (1) IL104169A0 (enExample)
IN (1) IN174405B (enExample)
MX (1) MX9207494A (enExample)
NO (1) NO942376L (enExample)
NZ (1) NZ246156A (enExample)
SI (1) SI9200408A (enExample)
SK (1) SK75094A3 (enExample)
WO (1) WO1993013097A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
AU733551B2 (en) * 1996-09-25 2001-05-17 Astrazeneca Ab Qinoline derivatives inhibiting the effect of growth factors such as VEGF
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
EP1192151B1 (en) 1999-07-09 2007-11-07 Glaxo Group Limited Anilinoquinazolines as protein tyrosine kinase inhibitors
US7160889B2 (en) 2000-04-07 2007-01-09 Astrazeneca Ab Quinazoline compounds
US6534656B2 (en) * 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
JP2003329989A (ja) * 2002-03-06 2003-11-19 Nippon Telegr & Teleph Corp <Ntt> 光送信装置
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
WO2005003100A2 (en) 2003-07-03 2005-01-13 Myriad Genetics, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
JP4503022B2 (ja) 2003-12-23 2010-07-14 ファイザー・インク 新規キノリン誘導体
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
US7915411B2 (en) * 2005-12-21 2011-03-29 Abbott Laboratories Anti-viral compounds
US7910595B2 (en) * 2005-12-21 2011-03-22 Abbott Laboratories Anti-viral compounds
TWI392676B (zh) * 2005-12-21 2013-04-11 Abbott Lab 抗病毒化合物、其製備方法及用途
EP2345652A1 (en) 2005-12-21 2011-07-20 Abbott Laboratories Antiviral compounds
CN102702194A (zh) * 2005-12-21 2012-10-03 雅培制药有限公司 抗病毒化合物
US8236950B2 (en) 2006-12-20 2012-08-07 Abbott Laboratories Anti-viral compounds
CA2727103A1 (en) * 2008-07-03 2010-01-07 Merck Patent Gmbh Naphthyridinones as aurora kinase inhibitors
EP2401275B1 (en) 2009-02-24 2013-07-24 Respiratorius AB Naphthyridine derivatives having bronchodilating activity
WO2011063398A1 (en) * 2009-11-23 2011-05-26 Cylene Pharamaceuticals, Inc. Polymorphs and salts of a kinase inhibitor
NZ603332A (en) 2010-04-02 2014-11-28 Senomyx Inc Sweet flavor modifier

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
EP0222839A4 (en) * 1985-05-17 1988-11-09 Univ Australian ANTI-MALARIA COMPOUNDS.
JPS6368568A (ja) * 1986-09-10 1988-03-28 Otsuka Pharmaceut Factory Inc ｐ−アミノフエノ−ル誘導体
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
JPH07116187B2 (ja) * 1987-07-22 1995-12-13 シェリング・コーポレーション 二環式化合物、それらを薬剤として使用すること、それらの製法、およびそれらの製造に有用な中間体
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 １，８−ナフチリジン−２−オン誘導体
JP3157077B2 (ja) * 1994-02-16 2001-04-16 内山工業株式会社 ベアリングシール

Also Published As

Publication number Publication date
FI943019A7 (fi) 1994-06-22
EP0618916B1 (en) 1998-09-23
JP2527917B2 (ja) 1996-08-28
BG98813A (bg) 1995-05-31
CN1096784A (zh) 1994-12-28
FI943019A0 (fi) 1994-06-22
NO942376D0 (enExample) 1994-06-22
JPH07502280A (ja) 1995-03-09
IL104169A0 (en) 1993-05-13
WO1993013097A1 (en) 1993-07-08
SI9200408A (en) 1993-09-30
CZ153594A3 (en) 1995-02-15
CA2125858A1 (en) 1993-07-08
ATE171452T1 (de) 1998-10-15
SK75094A3 (en) 1995-04-12
US5464781A (en) 1995-11-07
MX9207494A (es) 1993-07-01
HU9401877D0 (en) 1994-09-28
NO942376L (no) 1994-06-22
HUT66971A (en) 1995-01-30
DE69227125D1 (de) 1998-10-29
GB9127252D0 (en) 1992-02-19
NZ246156A (en) 1996-01-26
AU3158793A (en) 1993-07-28
EP0618916A1 (en) 1994-10-12
IN174405B (enExample) 1994-11-26
HRP921455A2 (en) 1994-12-31
DE69227125T2 (de) 1999-02-18

Similar Documents

Publication Publication Date Title
EP0618916B1 (en) Anti-rheumatic naphthyridine derivatives
US5780482A (en) Condensed 4-aminopyridines with antirheumatic activity
Cao et al. Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives
US5854257A (en) Naphthyridinone derivatives
JPH0327380A (ja) １ｈ―イミダゾ〔４，５―ｃ〕キノリン―４―アミン類
JP2021503438A (ja) Ｐａｄ阻害剤としての複素環式化合物
JPH0232058A (ja) ４―アミノ―３―カルボキシキノリン類およびナフチリジン類、製法および医薬用途
JPH0692407B2 (ja) Ｎ▲上６▼−ジ置換プリン誘導体、その製法及び該誘導体を含有するアレルギ−性疾患の治療剤
JPS60214787A (ja) ピラゾロピリジン誘導体．その製造方法及びその用途
EP0160578B1 (en) 1,8-naphthyridine derivatives
HU198048B (en) Process for production of derivatives of imidazo-piridine and medical preparatives containing these substances
SK284387B6 (sk) Beta-karbolínové deriváty s hypnotickými účinkami, spôsob ich prípravy a liečivo s ich obsahom
WO1995030676A1 (en) Antirheumatic 1-alkyl-4-hydroxy-3-(thien-3-yl) 1,8-naphthyridin-2(1h)-ones
US5712286A (en) Naphthyridine derivatives
WO1995007909A1 (en) Alkyl-1-alkyl-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxylates as anti-rheumatic agents
KR860001762B1 (ko) 7-아닐리노이소퀴놀린-5,8-퀴논의 제조방법
JPH0710863B2 (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
FI84723C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-(1,8-naftyridin-2-yl)-isoindolin-1-oner.
JPH02160780A (ja) アルコキシチオフェンカルボキシアミド誘導体、その製造方法及び該化合物を含有する医薬組成物
JP2004231514A (ja) ５−ｈｔ７受容体結合能を有し、かつ代謝的に安定なテトラヒドロベンズインドール誘導体
CS226022B2 (cs) Způsob přípravy piperidinopropylových derivátů
WO1993003036A1 (en) BENZOPYRANO[4,3-c]PYRAZOLES, THEIR PREPARATION AND THEIR USE AS IMMUNOMODULATORS
JPS61172880A (ja) ２−アミノ−５−オキソ−５Ｈ−〔１〕ベンゾピラノ〔２，３−ｂ〕ピリジン−３−カルボン酸誘導体およびその製造法